Abstract
Angiogenesis, invasion, and metastasis are the main events of cancer cells. JAK-1/STAT-3 is a key intracellular signaling transduction pathway, which controls the growth, differentiation, apoptosis, invasion, and angiogenesis of various cancer cells. The present study explored the impact of allyl isothiocyanate (AITC) on the JAK-1/STAT-3 pathway in DMBA-induced rat mammary tumorigenesis. The mammary tumor was initiated through a single dose of 25 mg DMBA/rat by a subcutaneous injection administered near the mammary gland. We observed decreased body weight and increased the total number of tumors, tumor incidence, tumor volume, well-developed tumor, and histopathological abnormalities in DMBA-induced rats that were modulated after being treated with AITC. Staining of mammary tissues showed a high accumulation of collagen in DMBA-induced rats and it was normalized by the AITC treatment. Moreover, DMBA-induced mammary tissues showed up-regulated expressions of EGFR, pJAK-1, pSTAT-3, nuclear fraction of STAT-3, VEGF, VEGFR2, HIF-1α, MMP-2, and MMP-9 and the down-regulated expressions of cytosolic fraction of STAT-3 and TIMP-2. Oral administration of AITC on DMBA-induced rats inhibits angiogenesis and invasion by modifying these angiogenic and invasive markers. The finding of the present study was further confirmed by molecular docking analysis that shows a strong binding interaction between AITC with STAT-3 and cocrystal structure of STAT-3 glide energy of −18.123 and −72.246 (kcal/mole), respectively. Overall, the results suggested that AITC inhibits activation of the JAK-1/STAT-3 pathway, which subsequently prevents angiogenesis and invasion. It was recommended that AITC might develop a beneficial effect against breast cancer.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- JAK:
-
Janus kinase
- STAT:
-
Signal transducer and activator of transcription
- EGF:
-
Epidermal growth factor
- EGFR:
-
Epidermal growth factor receptor
- AITC:
-
Allyl isothiocyanate
- H&E:
-
Hematoxylin and eosin
- MT:
-
Masson's tri-chrome
- PR:
-
Picrosirius red
- RT:
-
Reverse transcription
- PCR:
-
Polymerase chain reaction
- EtBr:
-
Ethidium bromide
- ECM:
-
Extracellular matrix
- BM:
-
Basement membrane
- ROS:
-
Reactive oxygen species
References
Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H (2006) Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091:151–169. https://doi.org/10.1196/annals.1378.063
Arivazhagan L, Sorimuthu Pillai S (2014) Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinoma. J Nutr Biochem 25:1140–1153. https://doi.org/10.1016/j.jnutbio.2014.06.007
Banerjee K, Resat H (2016) Constitutive activation of STAT3 in breast cancer cells: A review. Int J Cancer 138:2570–2578. https://doi.org/10.1002/ijc.29923
Bertl E, Bartsch H, Gerhäuser C (2006) Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 5:575–585. https://doi.org/10.1158/1535-7163.MCT-05-0324
Bhattacharya A, Li Y, Geng F, Munday R, Zhang Y (2012) The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer. Carcinogenesis 33:394–398. https://doi.org/10.1093/carcin/bgr283
Bourboulia D, Jensen-Taubman S, Rittler MR, Han HY, Chatterjee T, Wei B, Stetler-Stevenson WG (2011) Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment. Am J Pathol 179:2589–2600. https://doi.org/10.1016/j.ajpath.2011.07.035
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159. https://doi.org/10.1006/abio.1987.9999
Ciardiello F, Tortora G (2001) A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7:2958–2970
Darakhshan S, Bidmeshkipour A, Khazaei M, Rabzia A, Ghanbari A (2013) Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells. Asian Pac J Cancer Prev 14:6869–6874. https://doi.org/10.7314/apjcp.2013.14.11.6869
Davis L, Kuttan G (2001) Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol 75:165–168. https://doi.org/10.1016/s0378-8741(00)00404-9
Duffy MJ, Maguire TM, Hill A, McDermott E, O’Higgins N (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2:252–257. https://doi.org/10.1186/bcr65
Fang M, Yuan J, Peng C, Li Y (2014) Collagen as a double-edged sword in tumor progression. Tumour Biol 35:2871–2882. https://doi.org/10.1007/s13277-013-1511-7
Guruvayoorappan C, Kuttan G (2008) Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 30:711–727. https://doi.org/10.1080/08923970802278276
Hwang ES, Lee HJ (2006) Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells. Exp Biol Med (maywood) 231:421–430. https://doi.org/10.1177/153537020623100408
Jarnicki A, Putoczki T, Ernst M (2010) Stat3: linking inflammation to epithelial cancer-more than a “gut” feeling? Cell Div 5:14. https://doi.org/10.1186/1747-1028-5-14
Jezierska A, Motyl T (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15:32–40
Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW (2003) Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31–53. https://doi.org/10.1016/s0014-4827(02)00098-8
Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1–24. https://doi.org/10.1016/s0378-1119(02)00398-0
Klein T, Bischoff R (2011) Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41:271–290. https://doi.org/10.1007/s00726-010-0689-x
Korpanty G, Smyth E, Carney DN (2011) Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress? J Thorac Dis 3:19–29. https://doi.org/10.3978/j.issn.2072-1439.2010.11.11
Krasinskas AM (2011) EGFR Signaling in Colorectal Carcinoma. Patholog Res Int 2011:932932. https://doi.org/10.4061/2011/932932
Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M, Noshiro H (2016) Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer. Oncol Lett 11:1026–1034. https://doi.org/10.3892/ol.2015.4011
Kumar A, D’Souza SS, Tickoo S, Salimath BP, Singh HB (2009) Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. Integr Cancer Ther 8:75–87. https://doi.org/10.1177/1534735408330716
Kumar GS, Ramakrishnan V, Madhusudhanan N, Balasubramanian MP (2011) Antioxidant activity of Allyl isothiocyanate [AITC] against N-nitrosodiethylamine induced experimental liver carcinogenesis. J Pharm Res 4:3690–3694
Lai KC, Lu CC, Tang YJ, Chiang JH, Kuo DH, Chen FA, Chen IL, Yang JS (2014) Allyl isothiocyanate inhibits cell metastasis through suppression of the MAPK pathways in epidermal growth factor-stimulated HT29 human colorectal adenocarcinoma cells. Oncol Rep 31:189–196. https://doi.org/10.3892/or.2013.2865
Leeman-Neill RJ, Wheeler SE, Singh SV, Thomas SM, Seethala RR, Neill DB, Panahandeh MC, Hahm ER, Joyce SC, Sen M, Cai Q, Freilino ML, Li C, Johnson DE, Grandis JR (2009) Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis 30:1848–1856. https://doi.org/10.1093/carcin/bgp211
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Moselhy SS, Al mslmani MA, (2008) Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in sprague dawely female rats. Mol Cell Biochem 319:175–180. https://doi.org/10.1007/s11010-008-9890-6
Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC, Stack MS (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 279:39042–39050. https://doi.org/10.1074/jbc.M404958200
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366:2–16. https://doi.org/10.1016/j.gene.2005.10.018
Pecorino L (2012) Molecular biology of cancer: Mechanisms, targets and therapeutics. Oxford University Press, Oxford
Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677–684. https://doi.org/10.1038/nm0603-677
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437. https://doi.org/10.1038/nm.3394
Raica M, Cimpean AM, Ribatti D (2009) Angiogenesis in pre-malignant conditions. Eur J Cancer 45:1924–1934. https://doi.org/10.1016/j.ejca.2009.04.007
Rajakumar T, Pugalendhi P, Thilagavathi S (2015) Dose response chemopreventive potential of allyl isothiocyanate against 7,12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats. Chem Biol Interact 231:35–43. https://doi.org/10.1016/j.cbi.2015.02.015
Rajakumar T, Pugalendhi P, Jayaganesh R, Ananthakrishnan D, Gunasekaran K (2018a) Effect of allyl isothiocyanate on NF-κB signaling in 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea-induced mammary carcinogenesis. Breast Cancer 25:50–59. https://doi.org/10.1007/s12282-017-0783-y
Rajakumar T, Pugalendhi P, Thilagavathi S (2018b) Protective Effect of Allyl Isothiocyanate on Glycoprotein Components in 7,12-dimethylbenz(a)anthracene Induced Mammary Carcinoma in Rats. Indian J Clin Biochem 33:171–177. https://doi.org/10.1007/s12291-017-0663-4
Rajakumar T, Pugalendhi P, Thilagavathi S, Ananthakrishnan D, Gunasekaran K (2018c) Allyl isothiocyanate, a potent chemopreventive agent targets AhR/Nrf2 signaling pathway in chemically induced mammary carcinogenesis. Mol Cell Biochem 437:1–12. https://doi.org/10.1007/s11010-017-3091-0
Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900–911. https://doi.org/10.1038/nri1226
Spano JP, Fagard R, Soria JC, Rixe O, Khayat D, Milano G (2005) Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. Ann Oncol 16:189–194. https://doi.org/10.1093/annonc/mdi057
Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo. Carcinogenesis 24:1665–1670. https://doi.org/10.1093/carcin/bgg123
Têtu B, Brisson J, Wang CS, Lapointe H, Beaudry G, Blanchette C, Trudel D (2006) The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Res 8:R28. https://doi.org/10.1186/bcr1503
Thangarasu R, Pachaiappan P, Subbaiyan T (2020) Anti-estrogenic and anti-cell proliferative effect of allyl isothiocyanate in chemoprevention of chemically induced mammary carcinogenesis in rats. Pathol Oncol Res 26:913–925. https://doi.org/10.1007/s12253-019-00638-9
Thejass P, Kuttan G (2007) Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Integr Cancer Ther 6:389–399. https://doi.org/10.1177/1534735407309084
Wang G, Jing Y, Cao L, Gong C, Gong Z, Cao X (2016) A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway. Onco Targets Ther 10:55–66. https://doi.org/10.2147/OTT.S121619
Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67:2649–2656. https://doi.org/10.1158/0008-5472.CAN-06-1823
Yang DI, Chen SD, Yang YT, Ju TC, Xu JM, Hsu CY (2004) Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1. Br J Pharmacol 141:988–996. https://doi.org/10.1038/sj.bjp.0705687
Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137. https://doi.org/10.1038/35052073
Zhang Y (2010) Allyl isothiocyanate as a cancer chemopreventive phytochemical. Mol Nutr Food Res 54:127–135. https://doi.org/10.1002/mnfr.200900323
Zhang F, Li C, Halfter H, Liu J (2003) Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Oncogene 22:894–905. https://doi.org/10.1038/sj.onc.1206158
Acknowledgements
We gratefully acknowledged the financial assistance from the Indian Council of Medical Research (ICMR, Grant number-3/2/2/189/2013/NCD-III (OPA-27129)), in the form of a Senior Research Fellowship (SRF), New Delhi, India to the first author, Mr. T. Rajakumar.
Author information
Authors and Affiliations
Contributions
The authors declare that all data were generated in-house and that no paper mill was used. All authors contributed to the study's conception and design. Material preparation, data collection, and analysis were performed by [Thangarasu Rajakumar] and [Pachaiappan Pugalendhi]. The first draft of the manuscript was written by [Thangarasu Rajakumar] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that there are no conflicts of interest.
Additional information
Handling editor: S. Broeer.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rajakumar, T., Pugalendhi, P. Allyl isothiocyanate inhibits invasion and angiogenesis in breast cancer via EGFR-mediated JAK-1/STAT-3 signaling pathway. Amino Acids 55, 981–992 (2023). https://doi.org/10.1007/s00726-023-03285-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-023-03285-2